Home > Boards > Stock Clubs > Long-Term > Billionaire Boys Club Member Forum (BBCMF)

$$$$$$ the claw wins again $GDSI

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
The Claw Member Profile
 
Followed By 380
Posts 6,291
Boards Moderated 1
Alias Born 11/01/12
160x600 placeholder
Gilead Raises Fiscal Year Guidance; Remdesivir Added $1.9 Billion in 3Q Sales -- Earnings Review
Gilead Sciences Inc.'s third-quarter results beat Wall Street targets, helped by $1.9 billion in sales of its antiviral drug remdesivir that is used to treat hospitalized Covid-19 patients. Here's what you need to know:
DBV Technologies Down 16%
Wheat Higher on Tighter Global Supply -- Daily Grain Highlights
Front Month Nymex Natural Gas Fell 6.71% to Settle at $5.7820 -- Data Talk
Front Month Nymex RBOB Gasoline Fell 0.60% to Settle at $2.4350 -- Data Talk
Northrop Grumman Down Nearly 7%, Worst Performer in the S&P 500 So Far Today -- Data Talk
Shell's Emissions Commitment May Fall Short for Activist Investors -- ESG Insight
Activision Blizzard Ends Criticized Workplace Policy, Amid Probe -- ESG Insight
Spero Therapeutics Shares Rise 7% After NDA Submittal
BWX Technologies Shares Rise 6% After Contract From Energy Department
Generali Achieves Minimum Threshold for Cattolica Offer, Source Says
Top Company News of the Day
HCW Biologics Shares Double After FDA Clearance for Cancer Treatment Trial
publishSTOXX Europe 50 Index Ends 0.35% Higher at 3674.99 -- Data Talk
CAC 40 Index Ends 0.75% Higher at 6804.22 -- Data Talk
DAX Ends 0.06% Lower at 15696.33 -- Data Talk
FTSE 100 Index Ends 0.05% Lower at 7249.47 -- Data Talk
STOXX Europe 600 Index Ends 0.24% Higher at 475.16 -- Data Talk
FTSE 100 Falls as Shell Earnings Disappoint
EURO STOXX 50 Index Ends 0.31% Higher at 4233.87 -- Data Talk
Fluence Energy Shares Surge in Trading Debut After IPO
Cellnex's Nine-Month Loss Widened Amid String of Acquisitions
Manufacturing Activity in Central U.S. Picked Up Pace in October -- Kansas City Fed
Anheuser-Busch InBev Up Over 12%, On Track for Record Percent Increase -- Data Talk
Gilead Sciences to Report 3Q Results; Focus on Pandemic, Remdesivir Sales and HIV Business -- Earnings Preview
Personal Income Seen Down 0.4% -- Data Week Ahead
U.S. Pending Home Sales Fell in September, Missing Expectations -- NAR
Correction: Fitch Affirms Unicredit at 'BBB-'; Outlook Stable
The Claw   Tuesday, 10/20/15 04:16:04 PM
Re: The Claw post# 403961
Post # of 551437 
$$$$$$ the claw wins again $GDSI

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences